Rekombinanter EGFR (Cetuximab Biosimilar) Antikörper
Reaktivität: Human
FACS, BR
Wirt: Human
Monoclonal
C225
unconjugated
Recombinant Antibody
-
- Target Alle EGFR (Cetuximab Biosimilar) Produkte
- EGFR (Cetuximab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
-
Reaktivität
- Human
-
Wirt
-
Human
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser EGFR (Cetuximab Biosimilar) Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Blocking Reagent (BR)
- Spezifität
- Recognises human EGFR.
- Produktmerkmale
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Aufreinigung
- Purified antibody.
- Reinheit
- > 98 % as determined by SDS-PAGE
- Endotoxin-Niveau
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Immunogen
- The epidermal growth factor receptor is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands.
- Klon
- C225
- Isotyp
- IgG1 kappa
-
anti-EGFR (Cetuximab Biosimilar) antibody
Research Grade Reaktivität: Human ELISA Wirt: Maus Chimeric unconjugated Recombinant Antibody
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- EGFR (Cetuximab Biosimilar)
- Abstract
- EGFR (Cetuximab Biosimilar) Produkte
- Substanzklasse
- Biosimilar
- Hintergrund
- EGFR, ErbB-1, HER1, epidermal growth factor receptor
- UniProt
- P00533
-
Sie sind hier:
